Intellectual Property Rights and the Life Science Industries (Record no. 226864)

MARC details
000 -LEADER
fixed length control field 01692nam a22002177a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230313120431.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230302b ||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789812832276
040 ## - CATALOGING SOURCE
Transcribing agency AL
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 23
Classification number 346.048
Item number DUTI
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Graham Dutfield
9 (RLIN) 73836
245 ## - TITLE STATEMENT
Title Intellectual Property Rights and the Life Science Industries
Remainder of title Past Present and Future
250 ## - EDITION STATEMENT
Edition statement 2th ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London
Name of publisher, distributor, etc. World Scientific
Date of publication, distribution, etc. 2009
300 ## - PHYSICAL DESCRIPTION
Extent xiii,410p.
Other physical details HB
Dimensions 23x15cm.
365 ## - TRADE PRICE
Source of price type code General
Price type code ABDI/0658/23
Price amount ₹6837.00
Currency code
Unit of pricing ₹9116.00
Price note 25%
Price effective from 21/01/2023
520 ## - SUMMARY, ETC.
Summary, etc. This book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to “invent” life forms from scratch.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Source of heading or term Private law
Topical term or geographic name entry element Private law
9 (RLIN) 75196
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Cost, replacement price Price effective from Koha item type
    Dewey Decimal Classification     Bio Chemistry St Aloysius PG Library St Aloysius PG Library 02/28/2023 Academic Book Distributors 6837.00   346.048 DUTI PG024246 03/02/2023 9116.00 03/02/2023 Book